EDM2:XETRA:XETRA-

| Global Emerging Markets Equity |

Last Closing

USD 5.742

Change

-0.03 (-0.50)%

Market Cap

USD 5.01B

Volume

0.09M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the MSCI EM ESG Enhanced Focus Index.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-11 )

Largest Industry Peers for Global Emerging Markets Equity

Symbol Name Price(Change) Market Cap
IS3N:XETRA

-0.16 (-0.48%)

USD 23.27B
IBC3:XETRA

-0.02 (-0.48%)

USD 19.95B
XEMD:XETRA

-0.04 (-0.56%)

USD 5.42B
XMME:XETRA

-0.23 (-0.41%)

USD 5.42B
IQQE:XETRA

-0.14 (-0.34%)

USD 4.50B
36B5:XETRA

-0.02 (-0.40%)

USD 3.60B
QDVS:XETRA

-0.06 (-0.76%)

USD 3.60B
AYEM:XETRA

-0.02 (-0.34%)

USD 3.13B
EUNM:XETRA

-0.18 (-0.45%)

USD 2.91B
VFEA:XETRA

-0.31 (-0.49%)

USD 2.71B

ETFs Containing EDM2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Global Emerging Markets Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.29% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.29% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 18.45% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.45% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.56% 35% F 37% F
Dividend Return 2.56% 35% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.63% 46% F 56% F
Risk Adjusted Return 18.79% 28% F 32% F
Market Capitalization 5.01B N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.